Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2004-06-01
2010-12-14
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001490, C424S001650, C424S001730, C424S009600
Reexamination Certificate
active
07850946
ABSTRACT:
The sensitivity and specificity of the optical modality can be enhanced by the use of highly absorbing compounds as contrast agents. Novel macrocyclic cyanine and indocyanine bioconjugates that absorb and emit light in the near infrared region of electromagnetic spectrum are disclosed. These compounds are especially useful for endoscopic, localized photoacoustic, and sonofluorescence imaging, detection and therapy of tumors and other abnormalities.
REFERENCES:
patent: 5453505 (1995-09-01), Lee et al.
patent: 6217848 (2001-04-01), Achilefu et al.
patent: WO9617628 (1996-06-01), None
patent: WO9822146 (1998-05-01), None
patent: WO9848838 (1998-11-01), None
patent: WO9848846 (1998-11-01), None
Bremer, C., et al.; “Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes”, Radiology 222, pp. 814-818, 2002.
Brinkley M., “A Brief Survey of Methods for Preparing Protein Conjugates with Dyes, Haptens, and Cross-Linking Reagents”, Perspectives in Bioconjugate Chemistry, (Ed. Claude Meares, ACS Publication, Washington D.C.), pp. 59-70, 1993.
Bugaj, J.E., et al.; “Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye peptide conjugate platform”. Journal of Biomedical Optics, pp. 122-133, vol. 6, No. 2, Apr. 2001.
Dejong, M., et al. “Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy” Cancer Research 58; pp. 437-441, 1998.
Jain, R.K., “Barriers to Drug Delivery in Solid Tumors”, Scientific American, 271, pp. 58-65, 1994.
Lewis, J.S. et al., “Comparison of Four 64Cu-labeled Somatostatin Analogs in vitro and in a Tumor-bearing Rat Model: Evaluation of New Derivatives of PET Imaging and Targeted Radiotherapy” Journal of Medicinal Chemistry, 42, pp. 1341-1347, 1999.
Weissleder, R., “A clearer vision for in vivo imaging”, Nature Biotechnology, 19, 316-317, 2001.
Becker et al., “Transferrin-mediated tumor delivery of contrast media for optical imaging and magnetic resonance imaging”; Proceedings of biomedical imaging; reporters, dyes, and instrumentation, Jan. 26-28, 1999, pp. 142-150.
Patonay et al., “Near-Infrared Fluorogenic Labels: New Approach to an Old Problem”, Analytical Chemistry, vol. 63, No. 6, pp. 321A-327A.
International Search Report dated Dec. 27, 2004, 3 pages.
Achilefu Samuel
Ye Yunpeng
Jones D L
Washington University in St. Louis
LandOfFree
Macrocyclic cyanine and indocyanine bioconjugates provide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrocyclic cyanine and indocyanine bioconjugates provide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic cyanine and indocyanine bioconjugates provide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4231197